Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to evaluate the clinical safety and performance of Optibond Universal (OBU), a single component universal dental adhesive intended for indirect dental restorations according to manufacturer's Instruction For Use.


Clinical Trial Description

The device used in the study, Optibond Universal (OBU) is a single component universal dental adhesive intended for direct and indirect dental restorations. OBU is formulated to provide reliable bond strength with any etch technique, on all common substrates and in combination with any resin cement without auxiliary products (silane or metal primers) even in absence of light. OBU is intended for general population use by a dental professional. OBU contains an acidic component to etch the tooth surface in order to allow the adhesive to mechanically adhere to the prepared tooth surface. The adhesive can be used with light or without light cured prior to application of the restorative material. This allows for the adhesive to mechanically and chemically bond to the applied restorative material. OBU is formulated to provide a reliable bond strength, and it's compatible with all etching modes (self-etch, selective etch, and total etch). Aim/Hypothesis/Objective The primary objective of this study is to evaluate the clinical performance of OBU used in the intended clinical conditions. The device will undergo evaluation in the following categories: Functional Properties Endodontic posts Ceramic restorations Composite and metal crowns Pretreatment for indirect restorations Core build-ups Endpoints: Primary endpoints: Evaluation of clinical safety and performance of OBU, a single component universal dental adhesive intended for indirect dental restorations according to manufacturer's Instruction For Use. (Indirect metal restoration is defined as any restoration made of precious or non-precious alloy such as inlays, onlays, porcelain fused to metal, metal full coverage crown, metal full coverage fixed partial denture). All implant restorations are excluded. Secondary endpoints: Post-operative sensitivity, retention, general periodontal health, and general optical properties after baseline, 6 months, 1 year and 2 years post-placement. The hypothesis to be tested is that OBU is safe and effective in clinical settings when the device is used according to manufacturer's instructions: H0: P ̂_T-P ̂_C≥ ∆ HA: P ̂_T-P ̂_C< ∆ Where ∆ (delta) refers to the non-inferiority margin set at 10%. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06002880
Study type Interventional
Source Kerr Corporation
Contact
Status Terminated
Phase N/A
Start date July 14, 2023
Completion date February 8, 2024

See also
  Status Clinical Trial Phase
Completed NCT06242184 - Post-operative Sensitivity in Resin Composites N/A
Recruiting NCT05298059 - The Association of CPP-ACPF Associated With LASER in the Treatment of Tooth Sensitivity After at Home Bleaching N/A
Recruiting NCT05882760 - Postoperative Sensitivity Following Placement With Different Restorative Materials In Vital Posterior Teeth Phase 4
Not yet recruiting NCT06180707 - Pregabalin Gel in Reducing Post-operative Tooth Sensitivity Surgery Caused by Bleaching With 35% Hydrogen Peroxide Phase 3
Completed NCT06371092 - Efficacy of a Desensitizing Agent During At-home Bleaching Early Phase 1
Recruiting NCT04248803 - Evaluation of Gluma Desensitizer in Post-treatment Sensitivity in Posterior Composite N/A
Recruiting NCT06273930 - Reduction of Dentine Hypersensitivity After Use of Different Dentifrices Phase 1
Completed NCT06092567 - Post-operative Sensitivity in Composite Restorations N/A
Not yet recruiting NCT05789004 - Efficacy of Tooth Bleaching With 35% and 6% Hydrogen Peroxide in Primary Dentition Phase 1/Phase 2
Recruiting NCT05923294 - Two Different Graft Harvesting Techniques Applied in Localized Gingival Recessions N/A